Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University

Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University

Introduction: Hairy cell leukemia (HCL) is an indolent B-cell lymphoproliferative disease. BRAF V600E mutation is detected in nearly all classical HCL cases which offers the possibility of targeted therapy.Objective: The aim of our study was to assess the efficacy of low-dose vemurafenib as well as...

Full description

Saved in:
Bibliographic Details
Main Authors: Kata Ferenczi (Author), Zsófia Flóra Nagy (Author), Ildikó Istenes (Author), Hanna Eid (Author), Csaba Bödör (Author), Botond Timár (Author), Judit Demeter (Author)
Format: Book
Published: Frontiers Media S.A., 2023-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items